Patient perspectives on once-weekly medications for diabetes

Diabetes, Obesity and Metabolism

Volumn 13, Issue 2, 2011, Pages 144-149

  Polonsky, W H ^a,b   Fisher, L ^c   Hessler, D ^c   Bruhn, D ^d   Best, J H ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Behavioral Diabetes Institute   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ELI LILLY AND COMPANY   (United States)

^e AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

Diabetes mellitus type 2; Drug compliance; Medications; Patient perspectives; Type 2 diabetes

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; DIABETES CONTROL; DIABETES QUALITY OF LIFE; FEMALE; GLYCEMIC CONTROL; HEALTH SURVEY; HUMAN; INJECTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONCE WEEKLY THERAPY; PATIENT ATTITUDE; PATIENT COMPLIANCE; QUALITY OF LIFE;

EID: 78650644219     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2010.01327.x     Document Type: Article

References (13)

1. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27: 1218-1224.
2. Pladevall M, Divine G, Williams LK, Xi H, Potts LA, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004; 27: 2800-2805.
3. Ho PM, Rumsfeld JS, Masoudi FA et al. Effect of medication nonadherence on hospitalizations and mortality among patients with diabetes mellitus. Arch Intern Med 2006; 166: 1836-1841.
4. Fischer MA, Stedman MR, Lii J et al. Primary medication non-adherence: analysis of 195, 930 electronic prescriptions. J Gen Intern Med 2010; 25: 284-290.
5. Khan H, Lasker SS, Chowdhury TA. Prevalence and reasons for insulin refusal in Bangladeshi patients with poorly controlled Type 2 diabetes in East London. Diabet Med 2008; 25: 1108-1111.
6. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care 2005; 28: 2543-2545.
7. Larkin ME, Capasso VA, Chen CL et al. Measuring psychological insulin resistance: barriers to insulin use. Diabetes Educ 2008; 34: 511-517.
8. Drucker DJ, Buse JB, Taylor K et al. Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. Lancet 2008; 372: 1240-1250.
9. Bergenstal RM, Wysham C, MacConell L et al. Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial. Lancet 2010; 376: 431-439.
10. Saini SD, Schoenfeld P, Kaulback K, Dubinsky MC. Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care 2009; 15: e22-e33.
11. Cramer JA, Gold DT, Silverman SL, Lewiecki EM. A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 2007; 18: 1023-1031.
12. Claxton A, de Klerk E, Parry M, Robinson JM, Schmidt ME. Patient compliance to a new enteric-coated weekly formulation of fluoxetine during continuation treatment of major depressive disorder. J Clin Psychiatry 2000; 61: 928-932.
13. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care 2005; 28: 2543-2545.